These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25550556)

  • 1. Cancer stem cell marker in circulating tumor cells: expression of CD44 variant exon 9 is strongly correlated to treatment refractoriness, recurrence and prognosis of human colorectal cancer.
    Katoh S; Goi T; Naruse T; Ueda Y; Kurebayashi H; Nakazawa T; Kimura Y; Hirono Y; Yamaguchi A
    Anticancer Res; 2015 Jan; 35(1):239-44. PubMed ID: 25550556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of CD44 variant 9-expressing cancer stem cells might attenuate the efficacy of chemoradioselection and Worsens the prognosis of patients with advanced head and neck cancer.
    Aso T; Matsuo M; Kiyohara H; Taguchi K; Rikimaru F; Shimokawa M; Segawa Y; Higaki Y; Umeno H; Nakashima T; Masuda M
    PLoS One; 2015; 10(3):e0116596. PubMed ID: 25751671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of relevant markers of cancer stem cells in colorectal cancer - a meta analysis.
    Fan CW; Wen L; Qiang ZD; Chen T; Zhou ZG; Mo XM; Hu JK
    Hepatogastroenterology; 2012; 59(117):1421-7. PubMed ID: 22683959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.
    Pilati P; Mocellin S; Bertazza L; Galdi F; Briarava M; Mammano E; Tessari E; Zavagno G; Nitti D
    Ann Surg Oncol; 2012 Feb; 19(2):402-8. PubMed ID: 22071867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of p53 messenger ribonucleic acid expression in patients after curative resection for stage I to III colorectal cancer: association with colon cancer stem cell markers.
    Huh JW; Kim HR; Kim YJ
    J Am Coll Surg; 2013 Jun; 216(6):1063-9. PubMed ID: 23571142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer.
    Kobayashi K; Matsumoto H; Matsuyama H; Fujii N; Inoue R; Yamamoto Y; Nagao K
    Oncol Rep; 2016 Nov; 36(5):2852-2860. PubMed ID: 27599396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of CD44 expression in colorectal carcinomas.
    Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
    Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis.
    Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S
    J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characterisation of duodenal adenocarcinoma with high CD44 variant 9 expression.
    Maruyama Y; Uehara T; Daikuhara S; Kobayashi Y; Nakajima T; Matsumoto A; Tanaka E; Ota H
    Pathology; 2015 Dec; 47(7):647-52. PubMed ID: 26517627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 variant 9 expression as a predictor for gastric cancer recurrence: immunohistochemical and metabolomic analysis of surgically resected tissues.
    Yamakawa Y; Kusuhara M; Terashima M; Kinugasa Y; Sugino T; Abe M; Mochizuki T; Hatakeyama K; Kami K; Yamaguchi K
    Biomed Res; 2017; 38(1):41-52. PubMed ID: 28239031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
    Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
    Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
    Schulenburg A; Cech P; Herbacek I; Marian B; Wrba F; Valent P; Ulrich-Pur H
    J Pathol; 2007 Oct; 213(2):152-60. PubMed ID: 17708598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer.
    Bessa X; Elizalde JI; Boix L; Piñol V; Lacy AM; Saló J; Piqué JM; Castells A
    Gastroenterology; 2001 Apr; 120(5):1084-92. PubMed ID: 11266372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenase 1 expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
    Minato T; Yamamoto Y; Seike J; Yoshida T; Yamai H; Takechi H; Yuasa Y; Furukita Y; Goto M; Bando Y; Tangoku A
    Ann Surg Oncol; 2013 Jan; 20(1):209-17. PubMed ID: 22847125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer.
    Sawai K; Goi T; Kimura Y; Koneri K
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
    Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.